Nrf2 has also been shown to have an impact on the drug resistance of cancer (such as lung cancer, liver cancer, and thyroid cancer) to chemotherapy and radiotherapy (106–109). This evidence concerns the gene NFE2L2 and thyroid gland carcinoma.